Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Roper KJ. et al, (2023), Scientific Reports, 13
A multi-country analysis of COVID-19 hospitalizations by vaccination status
Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2
A review of new challenges and solutions to the timely and effective implementation of clinical research responses to high priority diseases of epidemic and pandemic potential: A scoping review protocol
Kadri-Alabi Z. et al, (2023), Open Research Europe, 3, 139 - 139
Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort.
Shah N. et al, (2023), Artificial organs, 47, 1490 - 1502
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Strategizing Across Organizations
Ramirez R. et al, (2023), MIT SLOAN MANAGEMENT REVIEW, 64, 62 - 65
Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number
Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737
Characterising Long Covid: a living systematic review update with controlled studies
Michelen M. et al, (2022)
Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID).
Pazukhina E. et al, (2022), BMC medicine, 20
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
Munblit D. et al, (2022), The Lancet. Respiratory medicine, 10, 715 - 724
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Knight SR. et al, (2022), Thorax, 77, 606 - 615
What comes next in the COVID-19 pandemic?
Fisher D. et al, (2022), Lancet (London, England), 399, 1691 - 1692
Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study.
Millar JE. et al, (2022), Scientific reports, 12
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.
Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234
Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study
Osmanov IM. et al, (2022), European Respiratory Journal, 59, 2101341 - 2101341
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Leclerc QJ. et al, (2021), BMC Health Services Research, 21
Research priorities for Long Covid: refined through an international multi-stakeholder forum
Carson G., (2021), BMC Medicine, 19
The value of open-source clinical science in pandemic response: lessons from ISARIC
Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
Hall MD. et al, (2021), eLife, 10
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
Evans RA. et al, (2021), The Lancet Respiratory Medicine, 9, 1275 - 1287
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
de Silva TI. et al, (2021), iScience, 24, 103353 - 103353
A prenylated dsRNA sensor protects against severe COVID-19
Wickenhagen A. et al, (2021), Science, 374
Are medical procedures that induce coughing or involve respiratory suctioning associated with increased generation of aerosols and risk of SARS-CoV-2 infection? A rapid systematic review.
Wilson J. et al, (2021), The Journal of hospital infection, 116, 37 - 46
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Abdukahil SA. et al, (2021), Infection, 49, 889 - 905
Characterising long COVID: a living systematic review
Michelen M. et al, (2021), BMJ Global Health, 6, e005427 - e005427
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19
Munblit D. et al, (2021), Clinical & Experimental Allergy, 51, 1107 - 1120
Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol
Sigfrid L. et al, (2021), The Lancet Regional Health - Europe, 8, 100186 - 100186
What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review
Michelen M. et al, (2021), F1000Research, 9, 1455 - 1455
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Russell CD. et al, (2021), The Lancet Microbe, 2, e354 - e365
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
Drake TM. et al, (2021), The Lancet, 398, 223 - 237
Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID‐19: Analysis of the ISARIC CCP‐UK Cohort
Yates T. et al, (2021), Obesity, 29, 1223 - 1230
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
Bloom CI. et al, (2021), The Lancet Respiratory Medicine, 9, 699 - 711
Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic review
Manoharan L. et al, (2021), PLOS ONE, 16, e0251250 - e0251250
Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
Norton A. et al, (2021), The Lancet Infectious Diseases, 21, 601 - 602
Priorities for COVID-19 research response and preparedness in low-resource settings
Norton AJ. et al, (2021), The Lancet, 397, 1866 - 1868
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
Gupta RK. et al, (2021), The Lancet Respiratory Medicine, 9, 349 - 359
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol
Sigfrid L. et al, (2021), BMJ Open, 11, e043887 - e043887
Prevalence of Asymptomatic SARS-CoV-2 Infection.
Cevik M. et al, (2021), Annals of internal medicine, 174, 283 - 284
A living mapping review for COVID-19 funded research projects: three-month update
Norton A. et al, (2020), Wellcome Open Research, 5, 209 - 209
Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review
Sigfrid L. et al, (2020), BMC Medicine, 18
Key clinical research questions asked during epidemic respiratory outbreaks: A systematic review
Harris C. et al, (2020), INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 101, 267 - 267
Ending COVID-19: progress and gaps in research-highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings.
COVID-19 Research GloPID-R Synergies Meeting Working Group None. and Meeting Co-chairs None., (2020), BMC medicine, 18
Development and validation of the 4C Deterioration model for adults hospitalised with COVID-19
Gupta RK. et al, (2020)